Education and training

1996-2004 Medical studies at Aarhus University

Experience

2013- Consultant in cardiology at Diagnostic Center Silkeborg

Responsibilities:

Main function in the Cardiac Medicine Joint Day Examination and co-responsible for the heart valve area.

Echocardiography: Responsible for the echocardiographic function. >10000 echocardiograms and >1000 TEE examinations.

Cardiac CT: Performed >1000 analyzes. Level 2 training at Johns Hopkins, Maryland

Functional manager in the cardiac medicine ward (2015-2020)

Educational responsibility for the cardiology main education. Including permanent representative for Silkeborg in the cardiology further education council, as well as recruitment committee (2017-)

In addition, cardiology on-call and ward rounds.

2017-2020 Consultant at Aleris Herning

2012-2013 Consultant at the medical department, Randers Regional Hospital

2009-2012 Main education Internal Medicine: Cardiology. Skejby Hospital. Union representative for Yngre Læger, Dept. B.

2007-2009 Main education Internal Medicine: Cardiology. Silkeborg Hospital.

2005-2007 Cardiology Dept. B, Skejby Hospital, Introductory position and another 9 months unclassified.

2005 Medical Dept., Fredericia Hospital, unclassified employment (3 months).

2004-2005 Internship at Fredericia Hospital. Department of Orthopaedic Surgery and Department of Medicine, cardiology section. Practice with Doctor Hilda Bang, Fredericia.

2001-2002 Orthopaedic Surgery Dept., Aarhus County Hospital, substitute doctor (6 months).

Other information

Publications:

Diederichsen ACP, Lindholt JS, Becker SW, Möller S, et al. Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial. Circulation. 2022;145(18):1387-1397. doi:10.1161/CIRCULATIONAHA.121.057008

Pedersen TGB, Sundbøll J, Becker SW, Grove EL, Terkelsen CJ, Pryds K. Ugeskr Laeger. 2021;183(45):V01210028.

Andersen A, Waziri F, Becker SW, Schultz JG, et al. Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial. BMC Pulm Med. 2021;21(1):72. Published 2021 Feb 28. doi:10.1186/s12890-021-01440-7

Becker S, Chisholm G, Maeng M. Positive predictive value of clinically suspected ST-segment elevation myocardial infarction using angiographic verification. Am J Cardiol. 2013;112(7):923-927. doi:10.1016/j.amjcard.2013.05.026

2014: GCP course, online training

2013: TULIP, phase 2, cholesterol trial (Sub-I)

2014: SPOCK, phase 2, cholesterol trial (Sub-I)

2014: EFC11569 of 11570 Odyssey Outcomes, phase 3, cholesterol trial (Sub-I)

2014: ENSURE, Edoxaban/warfarin in atrial fibrillation (C Sub-I

2014: DAN-NICAD, CAD score patch (Sub-I)

2015: EMANATE, Apixaban/warfarin in atrial fibrillation (Sub-I)

2015: SPIRE I and SPIRE II, PCSK9 trial (Sub-I)

2015: GEMINI/RIVAROXACS2002 (Sub-I)

2017: DalGenE, phase 3, Dalcetrapib (Sub-I)

2018: AEGIS II, phase 3, CSL112 (Sub-I)